Alterity Therapeutics (ATHE) vs Talphera (TLPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Talphera (TLPH) has outperformed Alterity Therapeutics (ATHE) over the past year, losing 16.7% versus a loss of 22.4%. Over five years, ATHE leads with a -74.7% price change compared with -94.9% for TLPH. Talphera is the larger company by market cap ($55.5 million vs $55.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATHE | TLPH |
|---|---|---|
| Share price | $3.04 | $1.07 |
| Market cap | $55.35M | $55.54M |
| 1-day change | -8.43% | +1.89% |
| YTD return | +7.79% | -7.89% |
| 1-year return | -22.43% | -16.67% |
| 5-year return | -74.66% | -94.85% |
| EPS (TTM) | $-0.90 | $-0.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.89 | $1.57 |
| 52-week low | $2.66 | $0.69 |
| Distance from 52-week high | -48.39% | -31.85% |
| Average volume | 16.33K | 251.66K |
| Shares outstanding | 18.21M | 51.91M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ATHE vs TLPH FAQ
Which is bigger, Alterity Therapeutics or Talphera?
Talphera (TLPH) is larger, with a market capitalization of $55.54M compared with $55.35M for Alterity Therapeutics (ATHE).
Which stock has performed better over the past year, ATHE or TLPH?
TLPH returned -16.67% over the past 12 months, compared with -22.43% for ATHE (price return, excluding dividends). Past performance does not predict future results.
Are Alterity Therapeutics and Talphera in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.